Both in Lab Analytical Instruments
Illumina vs Bio-Rad Laboratories
Over the past year ILMN returned +96.7% and BIO returned +19.5%; their daily moves had a correlation of 0.32.
ILMN +96.7% BIO +19.5%Growth of $1, one year, split-adjusted
| Metric | ILMN | BIO |
|---|---|---|
| Price | $235.99 | $372.18 |
| Market cap | $35.63B | $9.95B |
| Today | −18.64% | −3.18% |
| 1 month | −11.2% | +4.7% |
| 6 months | +73.8% | +45.1% |
| Year to date | +79.9% | +22.8% |
| 1 year | +148.3% | +16.5% |
| Revenue growth (YoY) | +4.2% | −0.1% |
| Gross margin | 73.5% | 53.1% |
| Net margin | 19.5% | 57.1% |
| P/E (TTM) | 39.8× | 44.7× |
| Price / sales | 7.9× | 3.8× |
| Net cash | -$452.0M | $414.8M |
| Dividend yield | — | — |
| Volatility (60d) | 66.6% | 27.7% |
| Short % of float | 5.5% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).